This is a decommissioned version of ERA which is running to enable completion of migration processes. All new collections and items and all edits to existing items should go to our new ERA instance at https://ualberta.scholaris.ca - Please contact us at erahelp@ualberta.ca for assistance!
Search
Skip to Search Results- 1Ex vivo extremity perfusion
- 1Ex-Situ Lung Perfusion
- 1Ex-vivo Lung Perfusion
- 1Ice recrystallization
- 1Limb transplantation
- 1Negative Pressure Ventilation
-
Spring 2020
By the year 2020, there is expected to be over 900,000 traumatic amputation survivors living in the United States alone(1). Unfortunately for these survivors, the potential of extremity transplantation is critically limited by the 4-6 hours of preservation time currently offered by standard cold...
-
Characterizing the Efficacy of Ice Recrystallization Inhibitors as a Novel Cryoprotectant for Lung Cryopreservation
DownloadFall 2020
Although lung transplant remains the only option for patients suffering from end-stage lung disease, donor lung supply is currently insufficient to meet demand. While many lungs become available for transplant, most are discarded due to failure to meet physiologic or compatibility criteria. Many...
-
Fall 2023
Lung transplantation is the gold-standard treatment for eligible patients with end-stage lung disease; however, there is an inadequate supply of high-quality donor lungs for transplant, resulting in a wait-list mortality of 15-30%. Ex-situ Lung Perfusion (ESLP) has become an established means of...